Page last updated: 2024-08-26

indo-1 and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

indo-1 has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, KM; Bonomi, P; Buyn, T; Dudeja, P; Harris, JE; Meng, J; Ou, D; Sawlani, D; Seed, T	1

Other Studies

1 other study(ies) available for indo-1 and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Article	Year
A 5-lipoxygenase inhibitor at micromolar concentration raises intracellular calcium in U937 cells prior to their physiologic cell death. Prostaglandins, leukotrienes, and essential fatty acids, 1997, Volume: 56, Issue:1 Topics: Amiloride; Apoptosis; Calcium; Cell Survival; DNA; Fluoresceins; Fura-2; Humans; Hydrogen-Ion Concentration; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipoxygenase Inhibitors; Male; Prostate; Trypsin; Tumor Cells, Cultured	1997

Article

Year

A 5-lipoxygenase inhibitor at micromolar concentration raises intracellular calcium in U937 cells prior to their physiologic cell death.

Prostaglandins, leukotrienes, and essential fatty acids, 1997, Volume: 56, Issue:1

Topics: Amiloride; Apoptosis; Calcium; Cell Survival; DNA; Fluoresceins; Fura-2; Humans; Hydrogen-Ion Concentration; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipoxygenase Inhibitors; Male; Prostate; Trypsin; Tumor Cells, Cultured

1997